AMPK Cancer Research Results
AMPK, adenosine monophosphate-activated protein kinase: Click to Expand ⟱
| Source: |
| Type: |
AMPK: guardian of metabolism and mitochondrial homeostasis; Upon changes in the ATP-to-AMP ratio, AMPK is activated. (AMPK) is a key metabolic sensor that is pivotal for the maintenance of cellular energy homeostasis. It is well documented that AMPK possesses a suppressor role in the context of tumor development and progression by modulating the inflammatory and metabolic pathways.
-Activating AMPK can inhibit anabolic processes and the PI3K/Akt/mTOR pathway reducing glycolysis shifting toward Oxidative Phosphorlylation.
AMPK activators:
-metformin or AICAR
-Resveratrol: activate AMPK indirectly
-Berberine
-Quercetin: may stimulate AMPK
-EGCG: thought to activate AMPK
-Curcumin: may activate AMPK
-Ginsenosides: Some ginsenosides have been associated with AMPK activation
-Beta-Lapachone: A natural naphthoquinone compound found in the bark of Tabebuia avellanedae (also known as lapacho or taheebo). It has been observed to activate AMPK in certain models.
-Alpha-Lipoic Acid (ALA): associated with AMPK activation
|
Park, Parkinson's Disease (PD): Click to Expand ⟱
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure.
-CoQ10 deficiency was observed at a higher frequency in Parkinson's disease
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *neuroP↑, *IL6↓, *IL1β↓, *NF-kB↓, *PGE2↓, *COX2↓, *MMP↑, *memory↑, *ROS↓, *Aβ↓, *HMGB1↓, TumCG↓, MARK4↓, Zeb1↓, MDM2↓, BNIP3↑, ASC↑, NLRP3↓, PI3K↓, Akt↓, Casp1↓, E-cadherin↑, STAT3↓, TLR4↓, MMP↓, ICAM-1↓, AMPK↓, IL6↑, MMP2↓, Warburg↓, Bcl-xL↓, Bcl-2↓, TumCCA↑, EMT↓, TumMeta↓, mTOR↓, HSP27↓, Casp3↑, GlucoseCon↓, lactateProd↓, VEGF↓, p‑p65↓, GIT1↓, FOXM1↓, cycD1/CCND1↓, CDK4↓, MMP9↓, HDAC2↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↓, 1, GlucoseCon↓, 1, lactateProd↓, 1, Warburg↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Bcl-2↓, 1, Bcl-xL↓, 1, Casp1↓, 1, Casp3↑, 1, MDM2↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP27↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
BNIP3↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK4↓, 1, cycD1/CCND1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
EMT↓, 1, FOXM1↓, 1, HDAC2↓, 1, mTOR↓, 1, PI3K↓, 1, STAT3↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
E-cadherin↑, 1, GIT1↓, 1, MARK4↓, 1, MMP2↓, 1, MMP9↓, 1, TumMeta↓, 1, Zeb1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
ASC↑, 1, ICAM-1↓, 1, IL6↑, 1, p‑p65↓, 1, TLR4↓, 1,
Protein Aggregation(tgid=19) ⓘ
NLRP3↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
FOXM1↓, 1, IL6↑, 1,
Total Targets: 39
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, ROS↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1, HMGB1↓, 1, IL1β↓, 1, IL6↓, 1, Inflam↓, 1, NF-kB↓, 1, PGE2↓, 1,
Protein Aggregation(tgid=19) ⓘ
Aβ↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
IL6↓, 1,
Functional Outcomes(tgid=23) ⓘ
memory↑, 1, neuroP↑, 1,
Total Targets: 14
Scientific Paper Hit Count for: AMPK, adenosine monophosphate-activated protein kinase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:75 Cells:% prod#:% Target#:9 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page